Association of Biliary Tract Disorders in Chronic Kidney Disease Patients and Its Related Risk Factors

Not yet recruiting

• Conditions: CKD; Gall Bladder Dysfunction
• Interventions: Diagnostic Test: abdominal ultrasonography.

• Registration Number: NCT06437418
• Lead Sponsor: Assiut University

Brief Summary

Our aim in this cross-sectional study is to determine the frequency and aspects of gallbladder dysfunction and the related risk factors in pre-ESRD and hemodialysis patients.

Detailed Description

Biliary tract disorders including cholelithiasis, cholecystitis, and other diseases of the biliary tract, are one of the most prevalent medical issues in the digestive system, posing a myriad of challenges for health workers and patients. Gallbladder dysfunction is the most frequent cause of symptomatic and complicated biliary tract disorders. Although gallbladder dysfunction is a common condition in Middle East countries, data on the incidence of end-stage renal disease (ESRD) are limited. The occurrence of gallbladder dysfunction in patients fed with low-protein diets suggests that gallbladder stones formation is affected by dietary protein content. Also the lithogenic composition changes of bile, increased nucleation tendency, and impaired motility of gallbladder are important factors in ESRD patients. It has been reported that chronic kidney disease (CKD) patients on regular hemodialysis (HD) have increased bile cholesterol levels and an increased bile saturation index. In addition, the gallbladder is innervated by the autonomic nervous system, which malfunctions in uremia, and it has been shown that gallbladder stasis might cause increased stone formation. In some studies, the prevalence of gallbladder dysfunction has been shown to increase in patients undergoing hemodialysis (HD) treatment for ESRD. So, we focused in this study to try to find association of gallbladder dysfunction in pre-dialysis ESRD and HD patient in comparison to normal renal function individuals.

Study Timeline

• Status Verified: 2024-05
• Study First Submitted: 2024-05-26
• Study First Submitted QC: 2024-05-30
• Last Update Submitted: 2024-05-30
• Study First Posted: 2024-05-31
• Last Update Posted: 2024-05-31
• Study Start: 2024-06
• Primary Completion: 2025-06
• Study Completion: 2025-07

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

• Patients who are diagnosed as CKD with eGFR according to Cockcroft-Gault Equation, whatever they are on regular hemodialysis or pre-dialysis without history of previous gallbladder dysfunction with normal renal function individuals.

Exclusion Criteria

• Patients who are younger than 18 years.
• Patients who are diabetic.
• Patients who have body mass index (BMI) more than 30.
• Patients who have family history of gallbladder disorder.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Group I	abdominal ultrasonography.	Gallbladder dysfunction in pre-dialysis CKD patients.
Group II	abdominal ultrasonography.	Gallbladder dysfunction in end stage CKD patients on dialysis.
Control Group	abdominal ultrasonography.	Gallbladder dysfunction in normal renal function participants (control group).

Primary Outcome Measures

Name	Time	Method
Gallbladder dysfunction in CKD patients	measuring fasting gallbladder volume (FV) after 10 overnight hours fasting and the residual gallbladder volume (RV) after 30 minutes after standard fixed meal	Evaluate the gallbladder ejection fraction (EF) which will be calculated by following formula. (EF = (fasting gallbladder volume (FV) - residual gallbladder volume (RV)) / fasting gallbladder volume (FV)x 100) EF = (FV - RV) / FV x 100

Trial Locations

Locations (1)

faculty of medicine Assiut university; 🇪🇬 Assiut, Egypt